Naim H Y
Institute of Microbiology, Heinrich-Heine University of Düsseldorf, Federal Republic of Germany.
Biochem J. 1993 Dec 15;296 ( Pt 3)(Pt 3):607-15. doi: 10.1042/bj2960607.
Human intestinal angiotensin-converting enzyme (ACE) exists in the brush-border membrane as a monomeric protein of apparent molecular mass 184 kDa. It is associated with the membrane via a hydrophobic segment and has a transmembrane orientation [Naim (1992) Biochem. J. 286, 451-457]. In addition to the membrane-bound form (ACEm), hydrophilic forms of ACE (ACEsec) can be identified in biosynthetically labelled intestinal cells. Thus the culture medium of biosynthetically labelled human biopsy samples contains an ACE molecule which has an apparent molecular mass similar to that of its membrane-bound counterpart. The secreted ACEsec forms follow a precursor/product relationship with the mature ACE molecule. The effect of the monomeric structure of ACE in its intracellular transport and secretion was investigated by pulse-chase experiments on human biopsy samples labelled with [35S]methionine. The results reveal 2-3-fold slower transport of ACE from the endoplasmic reticulum (ER) to the Golgi as compared with the homodimeric proteins dipeptidylpeptidase IV and aminopeptidase N. Further, the transport kinetics of ACE are comparable with those of human sucrase-isomaltase and human maltase-glucoamylase, two brush-border disaccharidases that do not form homodimers in the ER of human small-intestinal cells. These findings strongly suggest that homodimerization of brush-border proteins may influence the rate of transport of these proteins from the ER to the Golgi. The effect of glycosylation on the transport and secretion of ACE was investigated by utilizing several inhibitors of glycan processing. Here, secretion of ACE molecules continued to take place, albeit to a considerably lesser extent. In fact, approx. 2-fold less ACE molecules were secreted in the presence of inhibitors of ER glucosidases I and II and cis-Golgi mannosidase-I, suggesting that carbohydrate processing is important in the attainment of a transport-competent conformation.
人肠道血管紧张素转换酶(ACE)以一种表观分子量为184 kDa的单体蛋白形式存在于刷状缘膜中。它通过一个疏水片段与膜相连,并具有跨膜取向[Naim(1992年),《生物化学杂志》286卷,451 - 457页]。除了膜结合形式(ACEm)外,在生物合成标记的肠道细胞中还可鉴定出亲水性的ACE形式(ACEsec)。因此,生物合成标记的人活检样本的培养基中含有一种ACE分子,其表观分子量与其膜结合对应物相似。分泌的ACEsec形式与成熟的ACE分子存在前体/产物关系。通过对用[35S]甲硫氨酸标记的人活检样本进行脉冲追踪实验,研究了ACE单体结构在其细胞内运输和分泌中的作用。结果显示,与同二聚体蛋白二肽基肽酶IV和氨肽酶N相比,ACE从内质网(ER)到高尔基体的运输速度慢2 - 3倍。此外,ACE的运输动力学与人类蔗糖酶 - 异麦芽糖酶和人类麦芽糖酶 - 葡糖淀粉酶相当,这两种刷状缘双糖酶在人小肠细胞的内质网中不形成同二聚体。这些发现强烈表明,刷状缘蛋白的同二聚化可能会影响这些蛋白从内质网到高尔基体的运输速率。通过使用几种聚糖加工抑制剂,研究了糖基化对ACE运输和分泌的影响。在此,ACE分子的分泌仍在继续,尽管程度要小得多。事实上,在内质网葡糖苷酶I和II以及顺式高尔基体甘露糖苷酶 - I的抑制剂存在下,分泌的ACE分子大约减少了2倍,这表明碳水化合物加工对于获得具有运输能力的构象很重要。